NCT02253810View on ClinicalTrials.gov

Efficacy of Tranexamic Acid for Reducing Blood Loss and Blood Transfusion After Periacetabular Osteotomy

NACompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Dysplasia, Congenital Hip
Interventions
DRUG

Tranexamic Acid

Medication administered intra-operatively to promote blood clotting.

DRUG

Placebo

Saline solution

Trial Locations (1)

10021

Hospital for Special Surgery, New York

All Listed Sponsors
lead

Hospital for Special Surgery, New York

OTHER

NCT02253810 - Efficacy of Tranexamic Acid for Reducing Blood Loss and Blood Transfusion After Periacetabular Osteotomy | Biotech Hunter | Biotech Hunter